Myovant Sciences
Established in 2016, Myovant Sciences is a clinical-stage biopharmaceutical company. They are engaged in drug development, and committed to developing new treatments for women suffering from uterine fibroids, endometriosis, & infertility, and men suffering from prostate cancer. Myovant Sciences is Headquartered in London, England.
Last updated on
About Myovant Sciences
Founded
2016Estimated Revenue
$100M-$250MEmployees
251-1KFunding / Mkt. Cap
$418MCategory
Sector
Health CareIndustry Group
Pharmaceuticals, Biotechnology & Life SciencesIndustry
PharmaceuticalsSIC Code
87NAICs Code
3254Location
City
LondonCountry
United KingdomTech Stack (114)
